Emergency?Trouble breathing, chest pain, confusion, a seizure, or a child who is hard to wake: call 911 or go to an emergency department now.All warning signs
FluHubWeek ending Sep 26, 2026

If you have flu

Antiviral treatment for flu

Prescription antivirals shorten flu and lower the chance of serious complications. They work best when started within two days of the first symptom, and for some people they are recommended no matter how many days have passed.

Who should get an antiviral

CDC recommends starting antiviral treatment as soon as possible for anyone with suspected or confirmed flu who:[1]

  • is in the hospital with flu;
  • has severe, complicated, or worsening illness, at any point in the illness; or
  • is at higher risk of complications, such as adults 65 and older, young children, pregnant people, and people with conditions like asthma, diabetes, or heart disease.

For otherwise healthy people, a clinician can still prescribe an antiviral if it can be started within two days of getting sick.[1] Started in that window, treatment lessens symptoms and shortens illness by about a day.[3]

You usually do not need a flu test first.

CDC's guidance says treatment decisions "should not wait for laboratory confirmation of influenza." During flu season, a clinician can treat based on your symptoms.[1]

Timing

The two-day window applies to people who are otherwise healthy and have an ordinary course of flu. For people who are hospitalized, or whose illness is severe or getting worse, observational studies show benefit even when treatment starts after 48 hours, and CDC recommends treating them regardless of when symptoms began.[1][2]

The four FDA-approved flu antivirals

MedicineHow it's takenCourseApproved ages for treatmentGood to know
Oseltamivir
Tamiflu, generic
Capsule or liquid by mouthTwice a day for 5 days2 weeks and older (CDC also supports use in younger infants)[4][1]The preferred choice in pregnancy, for hospitalized patients, and for severe or worsening illness.[1] Taking it with food reduces nausea.
Baloxavir marboxil
Xofluza, generic since June 2026
Tablets by mouthOne dose5 years and older, healthy or higher-risk[5][8]CDC lists it alongside oseltamivir for higher-risk outpatients seen within 48 hours.[2] Not recommended in pregnancy, while breastfeeding, or alone for severely immunocompromised patients.[1] Do not take with dairy, calcium-fortified drinks, antacids, or supplements containing calcium, iron, magnesium, or zinc.[5]
Zanamivir
Relenza
Inhaled powderTwice a day for 5 days7 years and older[7]Not for people with asthma, COPD, or other airway disease, because it can trigger bronchospasm.[7][1] Contains milk proteins.
Peramivir
Rapivab
IV infusionOne dose6 months and older[6]Given in a clinic, urgent care, or emergency department for people who cannot take medicine by mouth.

Antibiotics do not treat flu. They are only used if a clinician finds a bacterial complication such as pneumonia.[3]

Special situations

Pregnancy and the 2 weeks after

Pregnant people and those up to two weeks postpartum are in a higher-risk group and should be treated promptly. Oral oseltamivir is preferred, at the same dose as for anyone else. Baloxavir is not recommended during pregnancy or breastfeeding.[1][2]

Children

Oseltamivir is dosed by weight and comes as a liquid. Children younger than 2 are a high-risk group and should be treated as soon as flu is suspected.[1][9] Baloxavir is not approved under age 5 because resistance emerged more often in younger children in trials.[5]

Never give aspirin or aspirin-containing products to anyone under 19 with flu: it can cause Reye syndrome, a rare but serious illness of the liver and brain.[12]

Kidney disease

Oseltamivir doses are reduced when kidney function is lower. Your clinician will adjust it; tell them about any kidney disease or dialysis.[4]

Severely weakened immune system

Oseltamivir is preferred. Baloxavir should not be used alone because resistance is more likely; a clinician may consider combining medicines.[2]

Side effects

The most common side effects of oseltamivir are nausea and vomiting, usually mild and less likely when it is taken with food. The label also notes rare reports of confusion or unusual behavior, mostly in children; flu itself can cause these, and the medicine's role has not been established.[4] Call your clinician if anything unusual happens.

After an exposure: preventing flu

Antivirals can also prevent flu after close contact with a sick person. This is mainly for people at very high risk (for example, a severely immunocompromised household member) for whom the vaccine is not an option or may not work well. It should start within 48 hours of the exposure and usually continues for 7 days after the last exposure.[9][1] For healthy people, CDC and IDSA generally prefer watching for symptoms and starting treatment early if they appear.[9]

Do the drugs still work?

Yes. Of more than 4,400 flu viruses CDC tested in the 2025–26 season, about 99% were susceptible to all four antivirals, and none showed reduced susceptibility to baloxavir.[10]

Taking care of yourself at home

  • Rest and drink plenty of fluids. Acetaminophen or ibuprofen can ease fever and aches if they are safe for you.
  • Stay home while you are sick. You can go back to normal activities once, for at least 24 hours, your symptoms are improving overall and you have had no fever without fever-reducing medicine. Take extra precautions for the next 5 days, such as a well-fitted mask around others.[11]
  • Watch for the emergency warning signs, especially a fever or cough that gets better and then comes back worse, which can signal pneumonia.

Longer read: TeleDirectMD's flu treatment guide covers medicines, home care, and recovery week by week.

Clinician detail: dosing

Oseltamivir treatment (5 days, twice daily)[4][1]

PatientDose
Adults and children over 40 kg75 mg BID
Children 23.1–40 kg60 mg BID
Children 15.1–23 kg45 mg BID
Children 15 kg or less (1 year and older)30 mg BID
Infants 2 weeks to under 1 year3 mg/kg BID
Preterm infants (CDC, off-label), by postmenstrual age<38 wk 1.0 mg/kg; 38–40 wk 1.5 mg/kg; >40 wk 3.0 mg/kg BID

Prophylaxis uses the same weight-based dose once daily. CDC supports prophylaxis from 3 months (3 mg/kg once daily under 1 year, off-label).[1]

Oseltamivir renal adjustment, adults[4]

CrCl (mL/min)TreatmentProphylaxis
>6075 mg BID75 mg daily
>30–6030 mg BID30 mg daily
>10–3030 mg daily30 mg every other day
ESRD on hemodialysis30 mg, then 30 mg after each HD session (max 5 days)30 mg after alternate sessions
ESRD on CAPD30 mg once30 mg weekly
ESRD not on dialysisNot recommended

Baloxavir[5][1]

Single oral dose within 48 hours of symptom onset (treatment) or of exposure (post-exposure prophylaxis), age 5 and older: 40 mg for 20 to under 80 kg; 80 mg for 80 kg or more. The label also describes granule packets for children 15 to under 20 kg (30 mg), but CDC notes the suspension is not currently available in the United States.

Zanamivir and peramivir[7][6]

Zanamivir: 10 mg (two 5-mg inhalations) BID for 5 days; prophylaxis 10 mg once daily. Peramivir: 600 mg IV once in adults and adolescents 13 and older; 12 mg/kg (max 600 mg) for ages 6 months to 12 years; reduce to 200 mg for CrCl 30–49 and 100 mg for CrCl 10–29. Peramivir is not recommended for prophylaxis, and CDC does not routinely recommend zanamivir, baloxavir, or peramivir for hospitalized patients.

Chemoprophylaxis duration

CDC and IDSA: 7 days after the last known exposure; in institutional outbreaks, at least 2 weeks and until 1 week after the last case is identified, for all residents regardless of vaccination.[1][9] The Tamiflu label lists at least 10 days for household prophylaxis; FluHub follows the CDC and IDSA duration.

Guideline status

The IDSA treatment guideline is the 2018 update (published 2019). It predates baloxavir's high-risk and pediatric indications, so CDC's March 2026 summary and December 2025 COCA guidance are the more current reference.[9][2]

Sources

  1. CDC. Influenza Antiviral Medications: Summary for Clinicians, updated March 10, 2026.
  2. CDC COCA Call. 2025–2026 Clinical Recommendations for Seasonal Influenza Prevention and Control (transcript), December 11, 2025.
  3. CDC. Treatment of Flu, updated September 2, 2025.
  4. Tamiflu (oseltamivir) prescribing information, DailyMed, December 2025.
  5. Xofluza (baloxavir marboxil) prescribing information, revised May 2025.
  6. Rapivab (peramivir) prescribing information, revised June 2024.
  7. Relenza (zanamivir) prescribing information, revised October 2023.
  8. FDA. FDA approves first single-dose generic treatment for influenza, June 17, 2026.
  9. Uyeki TM, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis 2019;68(6):e1–e47, current IDSA guideline.
  10. CDC FluView, Week 20 ending May 23, 2026 (antiviral susceptibility), May 29, 2026.
  11. CDC. Preventing Spread of Respiratory Viruses When You're Sick, updated August 18, 2025.
  12. MedlinePlus (NIH). Reye syndrome.
  13. CDC. People at Increased Risk for Flu Complications, updated September 11, 2024.